Fluoroscopy Equipment Market Size
The global fluoroscopy equipment market was valued at approximately USD 8.6 billion in 2025 and is projected to reach around USD 11.6 billion by 2033, growing at a CAGR of 6.6% during the forecast period from 2026 to 2033.
The global fluoroscopy equipment market is witnessing significant growth driven by the increasing prevalence of cardiovascular, orthopedic, gastrointestinal, and neurological disorders requiring real time diagnostic imaging and minimally invasive procedures. Rising adoption of image guided surgeries, increasing demand for interventional radiology procedures, and growing utilization of mobile C arm systems across hospitals and ambulatory surgical centers are further accelerating market expansion globally. In addition, continuous technological advancements such as digital flat panel detectors, AI assisted imaging software, low radiation dose systems, and high resolution real time visualization technologies are improving procedural precision, workflow efficiency, and patient safety across healthcare settings.
Fluoroscopy equipment is medical imaging equipment that displays the X-ray image on a monitor, the same as an X-ray movie. It uses X-rays to achieve real-time moving images of the inside of an object, like X-ray radiography and computed tomography. Fluoroscopy can be used to diagnose (determine the cause of) a health problem such as heart or intestinal disease. It is also used to guide treatments such as implants or injections and in orthopedic surgery. It allows the doctor to look inside organs, joints, muscles, and bones.
Fluoroscopy Equipment Market Summary
| Metrics | Details |
| Market CAGR | 5.22% |
| Segments Covered | By Product Type, By Application, By End-User, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
For More Insights Request Free Sample
Fluoroscopy Equipment Market Dynamics
Increasing number of interventional radiology procedures, the rising number of minimally invasive procedures, increased technological advancements, and the growing prevalence of cardiovascular diseases are some of the key market drivers of Global Fluoroscopy Equipment Market.
Latest innovations in fluoroscopic imaging equipment is expected to drive market growth.
ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, launched the FDA-approved ControlRad Trace in May 2019. ControlRad Trace is the only technology that can be integrated into existing mobile C-arms to reduce radiation in any fluoroscopic imaging procedure. Moreover, Corindus, a Siemens Healthineers company, announced in the published article “Circulation: Cardiovascular Interventions” in May 2020 states that robotic PCI with the CorPath GRX System reduces patient radiation exposure by 20% compared to manual PCI while increasing fluoroscopy time and contrast utilization. Thus, from the above-mentioned factors, the market is expected to drive in the forecast period.
The high cost of equipment is expected to hamper the market growth.
However, due to their advanced features and functionalities, mobile systems also have a high cost, which is more than USD 200,000. Advanced mobile units have 20KW generators attached, allowing them to penetrate dense tissues. The costliest ones manufactured by GE Healthcare include OEM 9900 Elite and Ziehm Imaging's vision RFD, which include large image displays to enable accurate image evaluation. Apart from the high equipment cost, there are other direct expenses for printers and DICOM boxes which increase the total cost of ownership. Due to this, the usage of the equipment is extended beyond its average life. Thus, from the above factors, the market is expected to be hampered in the forecast period.
Fluoroscopy Equipment Market Geographical Share
North America region holds the largest market share in the global fluoroscopy equipment
North America region accounted for the largest market share in 2021. The increasing prevalence of cardiovascular and orthopedic surgeries, high standards of healthcare infrastructure, the high frequency of diagnostic examination, the rising geriatric population, and the increasing prevalence of chronic diseases in the U.S. are the factors to drive the market in the forecast period. For instance, according to the Centers for Disease Control and Prevention, heart disease is the leading cause of death for both sexes and members of the majority of racial and ethnic groups in the U.S. Cardiovascular disease claims one life in the U.S. every 34 seconds. 1 in 5 deaths in the U.S. in 2020 was caused by heart disease, which affected approximately 697,000 people. Additionally, in 2020, adults under 65 years old accounted for about 2 in 10 deaths from CAD.
Moreover, because of its developed healthcare system, the U.S. has the largest installed base of C-arms globally. Additionally, all C-arms are replaced following the replacement schedule due to the strict regulations in the U.S., according to the healthcare regulatory authorities, which guarantees that the new C-Arm sales in the country are consistent. Thus, from the above factors, the North America region is expected to hold the largest market share in the forecast period.
Key Developments
February 2026: Rising adoption of AI-enabled fluoroscopy systems and advanced real-time imaging platforms across North America and Europe improved procedural accuracy and workflow efficiency in minimally invasive surgeries. Major companies including Siemens Healthineers, GE HealthCare, and Philips Healthcare accelerated deployment of low-dose fluoroscopy and smart imaging technologies.
January 2026: Increasing investments in hybrid operating rooms and interventional radiology infrastructure across the United States, Germany, China, and Japan strengthened demand for advanced fluoroscopy equipment. Canon Medical Systems and Shimadzu Corporation expanded fluoroscopy imaging portfolios supporting cardiovascular, orthopedic, and gastrointestinal procedures.
December 2025: Growing prevalence of cardiovascular disorders and rising demand for minimally invasive procedures across Asia-Pacific accelerated adoption of digital fluoroscopy systems and mobile C-arm technologies. Medtronic plc and Boston Scientific Corporation strengthened interventional imaging and surgical guidance solutions for precision treatment applications.
November 2025: Expansion of ambulatory surgical centers and outpatient imaging facilities across Europe and North America increased deployment of compact and portable fluoroscopy equipment. Hospitals and specialty clinics focused on advanced image-guided interventions with improved radiation safety and patient outcomes.
October 2025: Rising advancements in flat-panel detectors, AI-powered visualization software, and dose-reduction technologies improved image clarity and reduced radiation exposure during fluoroscopy-guided procedures globally. Research institutions in the United States accelerated innovation in virtual fluoroscopy and magnetic tracking technologies for interventional guidance.
September 2025: Increasing healthcare infrastructure modernization initiatives across India, Southeast Asia, and Middle East regions accelerated installation of advanced fluoroscopy systems in tertiary hospitals and specialty diagnostic centers. Mindray Medical International and Fujifilm Holdings Corporation expanded affordable imaging solutions targeting emerging healthcare markets.
August 2025: Growing demand for mobile C-arms and point-of-care fluoroscopy systems improved adoption of flexible imaging platforms across orthopedic, pain management, and trauma applications globally. Philips Healthcare introduced advanced motorized mobile C-arm systems supporting complex interventional procedures with enhanced imaging quality.
July 2025: Rising collaborations between imaging technology providers and healthcare institutions accelerated development of AI-integrated fluoroscopy platforms and advanced workflow management systems worldwide. Siemens Healthineers received regulatory clearance for advanced radiography and fluoroscopy systems supporting integrated diagnostic imaging applications.
June 2025: Increasing focus on minimally invasive surgeries and precision-guided interventions supported strong growth in fluoroscopy equipment adoption globally. North America maintained market leadership, while Asia-Pacific emerged as the fastest growing regional market driven by expanding healthcare investments and rising chronic disease burden.
Fluoroscopy Equipment Companies and Competitive Landscape
Major key players in the fluoroscopy equipment market include Siemens Healthcare, GE Healthcare, Philips Healthcare, Carestream Health, Inc., Canon Medical Systems, Hitachi Medical Systems, Shimadzu Corporation, Ziehm Imaging GmbH, Fujifilm Medical Systems and Lepu Medical Technology.
Shimadzu Corporation:
Overview:
Shimadzu Corporation is a Japanese public KK company that manufactures measuring devices, medical equipment, and precision instruments. In order to use advances in science and technology to make society more convenient, secure, and safe, the company operates in four segments: analytical and measuring instruments, medical systems, industrial machinery, and aircraft equipment. Shimadzu Scientific Instruments (SSI) is the Shimadzu Corporation's American subsidiary (Kyoto, Japan). SSI was founded in 1975 as a distribution hub that offered labs and service providers in the Americas analytical solutions. Shimadzu U.S.A. Manufacturing provides HPLC, GC-MS/MS, LC-MS/MS, and other high-tech products to the U.S. market through its ten regional offices strategically positioned across the country. These offices are staffed with experienced technical specialists, service and sales engineers, and a state-of-the-art Customer Training and Education Center.
Product Portfolio:
OPESCOPE ACTENO: It is a mobile C-arm Imaging System whose main applications are X-ray fluoroscopy and radiography during surgery. Lock mechanisms allow individual movement locking, ensuring quick and accurate positioning.
The global fluoroscopy equipment market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.
